4/16
11:15 am
MRNS
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Medium
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
4/16
08:13 am
MRNS
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $2.00 price target on the stock, down previously from $20.00.
Medium
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $2.00 price target on the stock, down previously from $20.00.
4/10
10:19 am
MRNS
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $28.00 price target on the stock.
Low
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $28.00 price target on the stock.
4/10
09:43 am
MRNS
Rating for MRNS
Low
Report
Rating for MRNS
3/26
08:13 am
MRNS
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Medium
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
3/7
08:25 am
MRNS
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $9.00 price target on the stock.
Medium
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $9.00 price target on the stock.
3/7
08:03 am
MRNS
Rating for MRNS
Medium
Report
Rating for MRNS
3/7
08:03 am
MRNS
Rating for MRNS
Medium
Report
Rating for MRNS
3/6
10:31 am
MRNS
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $24.00 price target on the stock.
Medium
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $24.00 price target on the stock.
3/6
10:31 am
MRNS
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $24.00 price target on the stock.
Medium
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $24.00 price target on the stock.
3/6
10:11 am
MRNS
Rating for MRNS
Medium
Report
Rating for MRNS
3/6
10:11 am
MRNS
Rating for MRNS
Medium
Report
Rating for MRNS
3/6
08:10 am
MRNS
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Low
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.